Content warning: Medical complications
This post discusses a sensitive topic. Open to read the rest.
October 1 is the first day most continental US clinics treat RSV antibody as in season. This card is the visit question, not a dose chart.
Background
Two products cover infants under 8 months: nirsevimab and clesrovimab, one dose, no AAP preference. Children 8 through 19 months on the high-risk list need nirsevimab only. Clesrovimab is not the second-season product. Palivizumab stopped after 31 December 2025. Maternal RSVpreF in late pregnancy, usually weeks 32 to 36, can cover a healthy term newborn if the dose was at least 14 days before birth.
What changed this morning
Immunize.org told practices on September 30 to recall babies born in late spring and summer before they turn 8 months and leave the routine first-season group. A November well visit can be too late for a baby who ages out in October. The AAP second-season expansion from September 2 — born before 32 weeks, significant heart disease, certain lung or neuromuscular conditions, Down syndrome or other chromosomal differences — is now in-window. Insurer formularies may still lag the recommendation.
Competing viewpoints
Birth hospitals that stock the antibody want the dose before discharge. Office-based clinics say allotments are uneven. Insurers have treated a nursery dose as a new billing line. Parents who already had the maternal vaccine can reasonably decline a duplicate first-season dose. That is not the same decision as a high-risk toddler entering a second season.
What to ask
- Did this baby get a maternal RSV vaccine at least 14 days before birth?
- If not, which product is in stock today, and is there a dose before we leave?
- If the child is 8 to 19 months, are they on the expanded high-risk list, and is the product nirsevimab?
- Will insurance need a prior authorization for a second-season dose?
What to watch next
Hospital floor stock this week, state Vaccines for Children allotments, and whether plans post the expanded second-season criteria before offices run short. Local health departments can start or extend outside October 1 to March 31 if activity warrants it.
Briefing only. Eligibility belongs with the clinician.
Sources: AAP News, September 2, 2026; Immunize.org IZ Express 1896, September 30, 2026; Contemporary Pediatrics, October 1, 2026.
Comments (0)
No comments yet.
Sign in to comment.